Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Baricitinib shows promise for treating alopecia areata with mild side effects.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Upadacitinib may effectively treat resistant lichen planopilaris.

A woman's hair turned white after taking a cancer drug called dasatinib.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

Ritlecitinib is an effective new treatment for Alopecia Areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Patients with alopecia areata prefer treatments that regrow scalp hair quickly over how often they need to take the medication.

Nucleic acid polymers can enhance antiviral responses and improve treatment outcomes for chronic hepatitis B.

Vorasidenib can cause unusual hair growth.

Securinine and ajmaline may effectively treat liver cancer, with securinine being less toxic to normal cells.

A woman lost all her body hair after hepatitis C treatment, but it started to grow back a year after stopping the treatment.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

Baricitinib is effective and safe for treating severe alopecia areata, promoting significant hair regrowth.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Switching from escitalopram to duloxetine improved hair loss.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.